Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

Novo Nordisk has entered into an exclusive license agreement with Lexicon Pharmaceuticals Inc. for LX9851, a first-in-class, ...

As part of the 2025 Nutrition for Growth Summit (N4G), hosted by the French Ministry for Europe and Foreign Affairs, The ...

German business-software group SAP claimed the top spot as Europe's largest company by market value, dethroning Danish pharmaceutical company Novo Nordisk.

Jason Stevens, CEO of Wayfairer Travel, says there are three “common sense” things anyone can do to make sure their next vacation is as good as it can be.

To be considered cost effective by a common measure used by health economists, the price of Novo Nordisk’s Wegovy would ... other drugs used for weight loss work? Here’s a primer.

Europe’s largest pharmaceutical firm, Novo Nordisk, has announced that it will offer its most popular weight-loss drug, Wegovy, for less than half of its listed price. This follows a similar ...

2seventy halts blood cancer trial, and other life science news 2seventy splits up again, with sale to Novo Nordisk 2seventy splits up again, with sale to Novo Nordisk Bluebird bio nets 3rd gene ...

Novo Nordisk launched a direct-to-consumer program last week to sell Wegovy at a reduced price for people who are uninsured or insured on commercial plans that don't cover the obesity drug. Through ...

The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun ...